Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19947313

A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer

Author
KATO, Takeshi1 ; MISHIMA, Hideyuki1 ; IKEDA, Kimimasa1 ; IKEDA, Masataka1 2 ; SEKIMOTO, Mitsugu1 2 ; SAKAMOTO, Junichi3 ; MONDEN, Morito1 2 ; IKENAGA, Masakazu1 ; MURATA, Kouhei1 ; ISHIDA, Hideyuki1 ; FUKUNAGA, Mutsumi1 ; OTA, Hirofumi1 ; TOMINAGA, Shusei1 ; OHNISHI, Tadashi1 ; AMANO, Masahiro1
[1] Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group, Suita, Osaka, Japan
[2] Graduate School of Medicine, Department of Surgery, Osaka University, Suita, Osaka, Japan
[3] Graduate School of Medicine, Social Life Science, Young Leaders' Program, Nagoya University, Nagoya, Aichi, Japan
Source

Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 2, pp 275-281, 7 p ; ref : 24 ref

CODEN
CCPHDZ
ISSN
0344-5704
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Springer, Berlin
Publication country
Germany
Document type
Article
Language
English
Author keyword
Colorectal cancer Combination chemotherapy Doxifluridine Irinotecan Phase II clinical trials
Keyword (fr)
Anticancéreux Association médicamenteuse Cancer colorectal Capécitabine Doxifluridine Essai clinique phase II Homme Irinotécan Métastase Stade avancé Traitement associé Camptothécine dérivé Cancer DNA topoisomerase Dérivé de la fluoropyrimidine Dérivé de la pyrimidine Enzyme Inhibiteur de la topoisomérase I Inhibiteur enzyme Isomerases Pathologie de l'appareil digestif Pathologie de l'intestin Pathologie du côlon Pathologie du rectum Pyrimidine nucléoside Tumeur maligne
Keyword (en)
Antineoplastic agent Drug combination Colorectal cancer Capecitabine Doxifluridine Phase II trial Human Irinotecan Metastasis Advanced stage Combined treatment Camptothecin derivatives Cancer DNA topoisomerase Fluoropyrimidine derivatives Pyrimidine derivatives Enzyme Topoisomerase I inhibitor Enzyme inhibitor Isomerases Digestive diseases Intestinal disease Colonic disease Rectal disease Pyrimidine nucleoside Malignant tumor
Keyword (es)
Anticanceroso Asociación medicamentosa Cancer de colon y recto Capecitabina Doxifluridina Ensayo clínico fase II Hombre Irinotecán Metástasis Estadio avanzado Tratamiento asociado Camptothecin derivado Cáncer DNA topoisomerase Fluoropirimidina derivado Pirimidina derivado Enzima Inhibidor topoisomerase I Inhibidor enzima Isomerases Aparato digestivo patología Intestino patología Colón patología Recto patología Pirimidina nucleósido Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B01 Tumors

Discipline
Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
19947313

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web